Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 74,785 | 43,407 | 15,879 | 101,418 | 84,817 |
| Depreciation Amortization | 2,090 | 1,801 | -644 | 4,829 | 2,222 |
| Income taxes - deferred | -25,821 | -16,964 | -6,726 | -33,905 | -29,438 |
| Accounts receivable | -3,569 | -1,496 | -1,500 | -3,432 | -1,789 |
| Accounts payable and accrued liabilities | 4,783 | -3,802 | -649 | 4,757 | 515 |
| Other Working Capital | 40,156 | 20,180 | 6,307 | 5,539 | -4,708 |
| Other Operating Activity | 28,728 | 25,117 | 13,290 | 41,117 | 35,316 |
| Operating Cash Flow | $121,152 | $68,243 | $25,957 | $120,323 | $86,935 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -298,846 | -88,815 | 0 | -355,066 | -258,422 |
| PPE Investments | -139 | -102 | N/A | -413 | -382 |
| Purchase Of Investment | 372,793 | 272,295 | 207,475 | 241,152 | 161,718 |
| Investing Cash Flow | $73,808 | $183,378 | $207,475 | $-114,327 | $-97,086 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,050 | 2,907 | 1,409 | 4,381 | 3,596 |
| Common Stock Repurchased | -145,428 | -145,428 | N/A | N/A | 0 |
| Other Financing Activity | -8,111 | -3,052 | -1,228 | -21,665 | -20,819 |
| Financing Cash Flow | $-149,489 | $-145,573 | $181 | $-17,284 | $-17,223 |
| Beginning Cash Position | 66,329 | 66,329 | 66,329 | 77,617 | 77,617 |
| End Cash Position | 111,800 | 172,377 | 299,942 | 66,329 | 50,243 |
| Net Cash Flow | $45,471 | $106,048 | $233,613 | $-11,288 | $-27,374 |
| Free Cash Flow | |||||
| Operating Cash Flow | 121,152 | 68,243 | 25,957 | 120,323 | 86,935 |
| Capital Expenditure | -139 | -102 | N/A | -413 | -382 |
| Free Cash Flow | 121,013 | 68,141 | 25,957 | 119,910 | 86,553 |